Steven E. Wilson, MD, received a bachelor’s degree in biology from California State University Fullerton and a master’s degree in molecular biology and biochemistry (Irvine) and an MD (San Diego) from the University of California.
His postgraduate training included an internship in internal medicine at Cedars-Sinai Medical Center in Los Angeles, and residency in ophthalmology at the Mayo Clinic." to "His postgraduate training included an internship in internal medicine at Cedars-Sinai Medical Center in Los Angeles, a residency in ophthalmology at the Mayo Clinic, and a fellowship in refractive surgery and cornea at the LSU Eye Center.
Dr. Wilson has received numerous awards from the medical community, including being listed in "The Best Doctors of America" numerous times. He was an RPB William and Mary Greve International Research Scholar and received the Manpower Award from the Research to Prevent Blindness, a RPB Physician-Scientist Award, the Senior Honor Award from the American Academy of Ophthalmology, and he was elected to the honorary American Ophthalmological Society. He is a diplomat of the American Board of Ophthalmology. Cataract and Refractive Surgery Today named him as one of the 50 most influential doctors in cataract and refractive surgery in May 2006. He received the Lans Distinguished Lecturer Award from the International Society of Refractive Surgery-American Academy of Ophthalmology in 2006. He received the Richard Lindstrom Career Award from CLAO at ASCRS in 2014. He received the 2020 Barraquer Award and Lecture from the International Society of Refractive Surgery-American Academy of Ophthalmology.
Wilson has edited many medical journals and papers, held national and international committee responsibilities under the auspices of organizations such as the National Institutes of Health, the Eye Bank Association of America, and Fight for Sight. He is a former trustee and vice president for the Association for Research in Vision and Ophthalmology (ARVO) the largest vision research organization in the world and served on the executive board for ISRS-AAO and is the program chairman for ISRS-AAO for 2006.
Wilson holds various medical patents; is a highly trained and skilled scientist and surgeon; has been awarded numerous research grants in the field of ophthalmology and vision research; and he has authored and presented more than 250 papers, medical books and book chapters. His research focuses on gene delivery to human cells using viral vectors, wound healing, and cytokines and receptors in eye tissues and breast tissues. His laboratory is funded by the National Eye Institute and the Department of Defense (DOD). He is also a leading expert in Dry Eye and Ocular Surface and helped design and implement the phase III clinical trial for topical cyclosporine for dry eye.
Dr. Wilson was selected as a finalist for the Benjamin Franklin Award for 2004 in the category Best New Voice in Fiction for his first international thriller Winter in Kandahar. His second international thriller, Ascent from Darkness, was released September 1, 2007 and was an honoree at the New York Book Festival and Hollywood Book Festival in 2007. The Benghazi Affair, the third book of The Stone Waverly Trilogy, was released in 2018 and was the Benjamin Franklin Award Audio Book of the Year in Fiction for 2019, as well as a finalist for the Eric Hoeffer Book of the Year award and a B.R.A.G. gold medal finalist for 2019. Dr. Wilson's fourth Novel "The Ghosts of Anatolia: An Epic Journey to Forgiveness: was published in 2010 and won the Foreword Reviews Book of the Year Award in Multicultural Fiction in 2010 and wasthe Runner-up Award for general fiction in the Hollywood Book Festival in 2011. His memoir "The Making, Breaking and Renewal of a Surgeon-Scientist: A Personal Perspective of the Physician Crisis in America" was published in 2019. All Dr. Wilson's books are available exclusively on Amazon.com and Audible.com.
Education & Fellowships
Fellowship - LSU Medical Center- University Hospital
Cornea & External Disease
Residency - Mayo Clinic
Rochester, MN USA
Internship - Cedars-Sinai Medical Center
Los Angeles, CA USA
Medical Education - University of California-San Diego School of Medicine
La Jolla, CA USA
Graduate School - University of California, Irvine
Molecular biology and biochemistry
Irvine, CA USA
Undergraduate - California State University at Fullerton
Awards & Honors
View publications for Steven Wilson, MD
(Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
de Oliveira RC, Tye G, Sampaio LP, Shiju TM, Dedreu J, Menko AS, Santhiago MR, Wilson SE. TGF1 and TGF2 proteins in corneas with and without stromal fibrosis: Delayed regeneration of epithelial barrier function and the epithelial basement membrane in corneas with stromal fibrosis. Exp Eye Res, 2021;202:108325 https://www.sciencedirect.com/science/article/abs/pii/S0014483520305832
Wilson SE. TGF beta -1, -2 and -3 in the modulation of fibrosis in the cornea and other organs. Exp Eye Res2021;207:108594.
Sampaio LP, Hilgert GSL, Shiju TM, Murillo SE, Santhiago MR, Wilson SE. Topical losartan inhibits corneal scarring fibrosis and collagen type IV deposition after Descemet’s membrane-endothelial excision in rabbits. Exp. Eye Res., 2022;216:108940. doi: 10.1016/j.exer.2022.108940.
Wilson SE. Defective perlecan-associated basement membrane regeneration and altered modulation of transforming growth factor beta in fibrosis. Cell. and Molec. Life Sci. 2022;79:144. doi: 10.1007/s00018-022-04184-7.
Sampaio LP, Hilgert GSL, Shiju TM, Santhiago MR, Wilson SE. Topical losartan and corticosteroid additivelyinhibit corneal stromal myofibroblast generation and scarring fibrosis after alkali burn injury. Trans Vis Sci Tech. 2022;11:9-15. doi: 10.1167/tvst.11.7.9.
Wilson SE. Topical losartan: Practical guidance for clinical trials in the prevention and
treatment of corneal scarring fibrosis and other eye diseases and disorders. J Ocular Pharm and Ther.
Wilson SE, Mohan RR, Netto MV, MD, et al. RANK, RANKL, OPG, and M-CSF expression in stromal cells during corneal wound healing. Invest. Ophthalmol. Vis. Sci, 2004;45:2201-2211.
Wilson SE, Mohan RR, Hutcheon AEK, Mohan RR, Ambrósio R, Zieske JD, Hong JW, Lee J-S. Effect of ectopic epithelial tissue within the stroma on keratocyte apoptosis, mitosis, and myofibroblast transformation. Exp Eye Res 2003;76 :193-201.
Netto MV, Mohan RR, Sinha S, Sharma A, Dupps W, Wilson SE. Stromal haze, myofibroblasts, and surface irregularity after PRK. Exp. Eye Res. 2006;82:788-97.